Cargando…
Clinical significance of polyglutamylation in primary central nervous system lymphoma
The therapeutic response to high-dose methotrexate (HD-MTX) therapy for primary central nervous system lymphoma (PCNSL) varies. Polyglutamylation is a reversible protein modification with a high occurrence rate in tumor cells. MTX incorporated into cells is polyglutamylated and strongly binds to dih...
Autores principales: | Shinojima, Naoki, Fujimoto, Kenji, Makino, Keishi, Todaka, Kohei, Yamada, Kazumichi, Mikami, Yoshiki, Oda, Kazutaka, Nakamura, Kazumi, Jono, Hirofumi, Kuratsu, Jun-ichi, Nakamura, Hideo, Yano, Shigetoshi, Mukasa, Akitake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389236/ https://www.ncbi.nlm.nih.gov/pubmed/29475458 http://dx.doi.org/10.1186/s40478-018-0522-4 |
Ejemplares similares
-
ML-03 RECONSIDERATION OF TREATMENT FOR ELDERLY PATIENTS WITH PRIMARY CENTRAL NERVE SYSTEM LYMPHOMAS
por: Shinojima, Naoki, et al.
Publicado: (2019) -
Oligodendrocyte Progenitor Cells and Macrophages/Microglia Produce Glioma Stem Cell Niches at the Tumor Border
por: Hide, Takuichiro, et al.
Publicado: (2018) -
GCT-36. TREATMENT RESULTS AND RADIATION-INDUCED TUMORS IN CASES OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR: A LONG-TERM FOLLOW-UP STUDY IN KUMAMOTO PREFECTURE
por: Yamamoto, Takahiro, et al.
Publicado: (2020) -
Antitumor effect of fibrin glue containing temozolomide against malignant glioma
por: Anai, Shigeo, et al.
Publicado: (2014) -
A case of suprasellar Erdheim-Chester disease and characterization of macrophage phenotype
por: Kai, Keitaro, et al.
Publicado: (2020)